ЗОЛГЕНСМА
Analogs of ЗОЛГЕНСМА
Find cheaper analogs and generic equivalents for ЗОЛГЕНСМА.
Active Ingredient: Onasemnogene abeparvovec
Product Overview
About ЗОЛГЕНСМА
ЗОЛГЕНСМА is a gene therapy medication used to treat Duchenne muscular dystrophy (DMD) in patients aged 5 and above. It contains the active ingredient Onasemnogene abeparvovec, which is a recombinant adeno-associated virus (AAV9) vector encoding the human dystrophin gene.
Key Benefits & Uses
- Treatment of Duchenne muscular dystrophy (DMD) in patients aged 5 and above
- Helps to reduce the frequency of hospitalizations due to respiratory events
- May improve muscle function and reduce muscle damage
Active Ingredient & Action
Onasemnogene abeparvovec works by delivering a healthy copy of the dystrophin gene to muscle cells, allowing them to produce a functional dystrophin protein. This helps to restore muscle function and reduce muscle damage in patients with DMD.
Important Notes
ЗОЛГЕНСМА is administered via intravenous infusion. Patients should be monitored for signs of an immune response, such as fever, rash, or muscle pain. Common side effects may include injection site reactions, headache, and fever. Patients should follow their doctor's instructions for use and report any concerns or side effects promptly.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.